Babies arriving 4 to 6 weeks early are significantly more likely to develop respiratory distress syndrome, sepsis, intraventricular hemorrhage, hypoglycemia, and jaundice requiring phototherapy
A recent retrospective study of spontaneous, low-risk, singleton, late preterm (between 34 and 37 weeks' gestation) deliveries finds that, compared with full-term infants, the babies arriving 4 to 6 weeks early were significantly more likely to develop respiratory distress syndrome (4.2% vs. 0.1%, P<.001), sepsis (0.4% vs. 0.04%, P<.001), intraventricular hemorrhage (0.2% vs. 0.02%, P<.001), hypoglycemia (6.8% vs. 0.4%, P<.001), and jaundice requiring phototherapy (18% vs. 2.5%, P<.001). The study, conducted in Israel, included almost 2,500 late preterm babies and almost 7,500 full-term controls.
The authors report that the relationship between gestational age and neonatal morbidity is of a continuous nature with a nadir at about 39 weeks' gestation. The relationship does not, as previously believed, have a term–preterm threshold, nor is it related to birthweight. They also found that among late-preterm babies, risk factors that further increase morbidity risk include cesarean delivery, male sex, and parity.
The authors concluded that given the short- and long-term neonatal morbidity, hospitalization days, and costs associated with late prematurity, practitioners may want to consider doing more to prolong pregnancy when spontaneous preterm labor occurs beyond 34 weeks' gestation.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More